ARID1A Mutation in Metastatic Breast Cancer: A Potential Therapeutic Target
Distant metastasis is the principal cause of mortality for breast cancer patients. Targeting specific mutations that have been acquired during the evolution process of advanced breast cancer is a potential means of enhancing the clinical efficacy of treatment strategies. In metastatic breast cancer,...
Guardado en:
Autores principales: | Xuan Cheng, Jian-Xiong Zhao, Feng Dong, Xu-Chen Cao |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cb7b9d2bd5ac409393c064b6b03f2372 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Single-PanIN-seq unveils that ARID1A deficiency promotes pancreatic tumorigenesis by attenuating KRAS-induced senescence
por: Shou Liu, et al.
Publicado: (2021) -
Identification of de novo mutations for ARID1B haploinsufficiency associated with Coffin–Siris syndrome 1 in three Chinese families via array-CGH and whole exome sequencing
por: Guanting Lu, et al.
Publicado: (2021) -
Acute depletion of the ARID1A subunit of SWI/SNF complexes reveals distinct pathways for activation and repression of transcription
por: Seraina Blümli, et al.
Publicado: (2021) -
Metastatic breast cancer: Endocrine therapy landscape reshaped
por: Mohamad Adham Salkeni, et al.
Publicado: (2017) -
The Genomic Landscape of the Fungus-Specific SWI/SNF Complex Subunit, Snf6, in <named-content content-type="genus-species">Candida albicans</named-content>
por: Faiza Tebbji, et al.
Publicado: (2017)